Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smartwatch and remote coaching cut incontinence after prostate surgery?

NCT ID NCT06981026

Symptom relief Sponsor: University Hospital Olomouc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a structured telemedicine program — including wearable activity monitors, breathing exercises, and remote physiotherapy — can reduce urinary incontinence after radical prostatectomy for localized prostate cancer. Two hundred men scheduled for surgery will be enrolled and followed to see if the program improves continence recovery, walking distance, balance, and muscle strength compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a telemedicine-based prehabilitation and rehabilitation program using wearable devices and remote physiotherapy consultations
What this could lead to
If effective, this approach could offer a convenient, home-based way to speed up continence recovery and improve quality of life after prostate cancer surgery.
What could go wrong
This is a single-center trial, and results may not apply to all patients. The program relies on patient adherence and technology access, which could limit its real-world impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Biopsy-confirmed localized prostate cancer (ICD code C.61). * Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND). * Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter. * No known urethral stricture or colostomy or chronic urinary catheterization. * No medical or current psychiatric disorders that precludes their participation in the study. * Status of the musculoskeletal system allowing physical exercise. * Urinary continent at baseline. * Has reliable internet and the skills/knowledge to use technologies use for the study. Exclusion criteria: * Other malignant tumors, except for benign skin carcinoma. * Active treatment for other oncological diagnoses. * Presence of preoperative urinary incontinence. * Diagnosed mental or cognitive disorders. * Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence. * Severe musculoskeletal disorders preventing active exercise * Inability to use required technologies

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Localized prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prehabilitation Prostatectomy Telemedicine

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Urology clinic, University hospital Olomouc

    RECRUITING

    Olomouc, 77900, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.